Skip to content
Open access

Lamotrigine Attenuates Lipopolysaccharide-Induced Working-Memory Impairment and Is Associated with Changes in Neuroinflammatory, Oxidative-Stress, and Apoptosis-Related Markers

Sep 2026 · Brain Science · Vol 16, pp. 971 · 0 citations · 60 references
Medicine

TL;DR

LTG effectively attenuated LPS-induced cognitive impairment and neuroinflammatory responses, accompanied by improvements in oxidative stress- and apoptosis-related markers, which support the potential preventive or neuroprotective effects of LTG against neuroinflammation-associated working-memory impairment.

Abstract

Highlights What are the main findings? Lamotrigine (LTG) ameliorated lipopolysaccharide (LPS)-induced working-memory impairment and suppressed neuroinflammatory responses in the prefrontal cortex. LTG reduced oxidative stress and pro-apoptotic signaling while restoring endogenous antioxidant and anti-apoptotic defenses. What are the implications of the main findings? LTG may exert neuroprotective effects through coordinated regulation of inflammatory, oxidative, and apoptotic pathways. These findings support further investigation of LTG as a potential therapeutic strategy for inflammation-associated working-memory impairment. Abstract Background/Objectives: Persistent neuroinflammation, oxidative imbalance, and neuronal apoptosis are key mechanisms underlying memory loss and working-memory impairment in many neurodegenerative conditions. LTG, an established anticonvulsant recognized for its glutamate-modulating and immune-dampening actions, has been reported to exert neuroprotective actions beyond seizure control. This study investigated whether LTG can counteract LPS-induced deficits in cognition and neuroinflammatory responses in rats by modulating oxidative stress- and apoptosis-related markers. Methods: A total of twenty-four rats were allocated into four different groups: Control, LPS, LTG, and LTG + LPS. LTG (30 mg/kg, orally) was administered for 15 days, whereas LPS (1 mg/kg, intraperitoneally) was administered during the final four days to provoke neuroinflammation. Working memory abilities were assessed utilizing the Y-maze spontaneous alternation test. Subsequently, brain tissues were analyzed for inflammatory mediators (COX-2, TNF-α, IL-6), apoptotic markers (Caspase-3, Bcl-2, BAX), and oxidative stress indicators (MDA, GSH, catalase). Results: LPS exposure produced significant memory deterioration, accompanied by elevated COX-2, TNF-α, IL-6, and MDA levels, along with reduced GSH and catalase activity, indicating oxidative and inflammatory stress. BAX and Caspase-3 expression were markedly enhanced, whereas Bcl-2 expression was significantly reduced. Pretreatment with LTG markedly attenuated the LPS-induced decline in Y-maze performance, cytokine elevation, and alterations in redox and apoptotic parameters. Conclusions: LTG effectively attenuated LPS-induced cognitive impairment and neuroinflammatory responses, accompanied by improvements in oxidative stress- and apoptosis-related markers. These findings support further investigation of the potential preventive or neuroprotective effects of LTG against neuroinflammation-associated working-memory impairment.

Read PDF

Similar papers

Nov 2026

Hippocampal HMGB1/TLR4 activation elevates KYNA levels and contributes to novel-object recognition dysfunction in LPS-treated mice.

BACKGROUND Neuroinflammation is a major contributor to cognitive dysfunction, yet the mechanisms linking inflammatory signaling to synaptic dysfunction remain incompletely understood. Kynurenic acid (KYNA), an endogenous metabolite derived from tryptophan catabolism, modulates neuronal and synaptic activity, yet its in...

Ting Liu, Si-Yi Han, Xiao-Yu Zhang et al. · 0 citations
Open access Oct 2026

Hydroxytyrosol Attenuates Reserpine-Induced Parkinsonism and Hippocampal Damage by Downregulating Pro-inflammatory MAPK/AP-1-Related Gene Expression

Findings suggest that HT’s effects against RES-induced neuronal injury are associated with transcriptional downregulation of these genes, supporting its potential as a supportive approach to mitigate inflammation and preserve cognitive function in this Parkinsonian-like model.

Masoud Basaeidooei, M. Edalatmanesh, M. Forouzanfar · 0 citations
Open access Nov 2026

FAAH Inhibition with URB-597 Mitigates Neuroinflammation-Associated Deficits in Working and Recognition Memory in Male Rats

Introduction. Neuroinflammation contributes to cognitive decline by impairing learning, memory, and synaptic plasticity. Systemic lipopolysaccharide (LPS) is widely used to model inflammation-associated behavioral and cognitive changes. The endocannabinoid system (ECS) modulates stress responses, synaptic signaling, an...

Héctor A. López-Rivera, A. Frontera, Ema Abreu et al. · 0 citations
2026

Protective effects of vitamin B12 against LPS-induced cognitive impairment through modulation of neuroinflammation, oxidative stress, and cholinergic dysfunction

Objective(s): Neuroinflammation is a key pathological driver of cognitive impairment in neurodegenerative diseases. The endotoxin lipopolysaccharide (LPS) is used to model neuroinflammation, memory impairment, and neurodegeneration. Vitamin B12 has been extensively studied as an anti-oxidant and anti-inflammatory compo...

Zahra Khosravi, Rasul Saberi, Sajjad Mollaei et al. · 0 citations
Open access Nov 2026

Sodium Phenylbutyrate Attenuates Hippocampal Redox Imbalance, Neuroinflammation, and Recognition Memory Impairment in Rats with CCl4-Induced Hyperammonemia

Chronic hyperammonemia (HA) secondary to liver dysfunction is associated with cognitive impairment, oxidative stress, and neuroinflammation, particularly in hippocampal regions involved in learning and memory. This exploratory study evaluated the effects of sodium phenylbutyrate (PBA) on behavior and on biochemical and...

Daniel Juárez-Serrano, Berenice Venegas, S. Treviño et al. · 0 citations
Nov 2026

The neuroprotective efficacy of cholecalciferol: Targeting oxidative stress and NF-κB-mediated neuroinflammation in a valproic acid-induced autism model.

BACKGROUND Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition characterized by repetitive behaviors, heightened anxiety and altered exploratory motivation, which are closely linked to oxidative stress, neuroinflammation, and glial dysfunction. Although vitamin D₃ (cholecalciferol) exhibits...

M. Eldesoqui, O. Erfan, R. Sherif et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.